Innovation Pharmaceuticals Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Innovation Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $55K, a 6.78% decline year-over-year.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $197K, a 20.1% increase from 2022.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $164K, a 22.4% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2021 was $134K, a 42.5% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $197K +$33K +20.1% Jul 1, 2022 Jun 30, 2023 10-K 2023-09-28
2022 $164K +$30K +22.4% Jul 1, 2021 Jun 30, 2022 10-K 2022-09-28
2021 $134K -$99K -42.5% Jul 1, 2020 Jun 30, 2021 10-K 2021-09-27
2020 $233K Jul 1, 2019 Jun 30, 2020 10-K 2020-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.